Cilofungin

Cilofungin
Names
	IUPAC name N-[(11R,20R,21R,25S,26S)-6-[(1S,2S)-1,2-Dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis(1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-(octyloxy)benzamide
	Other names 1-[(4R,5R)-4,5-Dihydroxy-N2-[p-(octyloxy)benzoyl]-L-ornithine]echinocandin B [1] ; (4R,5R)-4,5-Dihydroxy-N2-[p-(octyloxy)benzoyl]-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6→1)-peptide [1]
Identifiers
CAS Number	79404-91-4 ;
3D model (JSmol)	Interactive image ;
ChEMBL	ChEMBL2103748 ;
ChemSpider	5293334 ;
MeSH	Cilofungin
PubChem CID	6918120 ;
UNII	8ZJC54A39X ;
	InChI InChI=1S/C49H71N7O17/c1-5-6-7-8-9-10-19-73-31-17-13-28(14-18-31)42(65)50-32-21-34(61)45(68)54-47(70)38-39(62)24(2)22-56(38)49(72)36(26(4)58)52-46(69)37(41(64)40(63)27-11-15-29(59)16-12-27)53-44(67)33-20-30(60)23-55(33)48(71)35(25(3)57)51-43(32)66/h11-18,24-26,30,32-41,45,57-64,68H,5-10,19-23H2,1-4H3,(H,50,65)(H,51,66)(H,52,69)(H,53,67)(H,54,70)/t24-,25+,26+,30+,32-,33-,34+,35-,36-,37-,38-,39-,40-,41-,45+/m0/s1 Key: ZKZKCEAHVFVZDJ-MTUMARHDSA-N ; InChI=1/C49H71N7O17/c1-5-6-7-8-9-10-19-73-31-17-13-28(14-18-31)42(65)50-32-21-34(61)45(68)54-47(70)38-39(62)24(2)22-56(38)49(72)36(26(4)58)52-46(69)37(41(64)40(63)27-11-15-29(59)16-12-27)53-44(67)33-20-30(60)23-55(33)48(71)35(25(3)57)51-43(32)66/h11-18,24-26,30,32-41,45,57-64,68H,5-10,19-23H2,1-4H3,(H,50,65)(H,51,66)(H,52,69)(H,53,67)(H,54,70)/t24-,25+,26+,30+,32-,33-,34+,35-,36-,37-,38-,39-,40-,41-,45+/m0/s1 Key: ZKZKCEAHVFVZDJ-MTUMARHDBF;
	SMILES O=C2N5[C@H](C(=O)N[C@H](O)[C@H](O)C[C@H](NC(=O)c1ccc(OCCCCCCCC)cc1)C(=O)N[C@H](C(=O)N4[C@H](C(=O)N[C@H](C(=O)N[C@H]2[C@H](O)C)[C@H](O)[C@@H](O)c3ccc(O)cc3)C[C@@H](O)C4)[C@H](O)C)[C@@H](O)[C@@H](C)C5;
Properties
Chemical formula	C49H71N7O17
Molar mass	1030.12474
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

Last updated October 05, 2020

Cilofungin (INN)^[1] is the first clinically applied member of the echinocandin family of antifungal drugs. It was derived from a fungus in the genus Aspergillus . It accomplishes this by interfering with an invading fungus' ability to synthesize the cell wall (specifically, it inhibits the synthesis of (1→3)-β-D-glucan).^[2]

Related Research Articles

An international nonproprietary name (INN) is an official generic and non-proprietary name given to a pharmaceutical drug or an active ingredient. INNs are intended to make communication more precise by providing a unique standard name for each active ingredient, to avoid prescribing errors. The INN system has been coordinated by the World Health Organization (WHO) since 1953.

Mitiglinide is a drug for the treatment of type 2 diabetes.

Bradanicline is a drug which was being developed by Targacept that acts as a partial agonist at the α7 subtype of the neural nicotinic acetylcholine receptors. It showed cognitive enhancing effects in animal studies, and was being developed through a collaboration between Targacept and AstraZeneca as a potential treatment for schizophrenia and attention deficit disorder. Phase I clinical trials were completed successfully, and it was in phase II trials.

Carburazepam is a drug which is a benzodiazepine derivative.

Acefylline (INN), also known as acetyloxytheophylline, is a stimulant drug of the xanthine chemical class. It acts as an adenosine receptor antagonist. It is combined with diphenhydramine in the pharmaceutical preparation etanautine to help offset diphenhydramine induced drowsiness.

Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs. In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are the International Nonproprietary Names (INNs); and trade names, which are brand names. Generic names for drugs are nowadays constructed out of affixes and stems that classify the drugs into different categories and also separate drugs within categories. A marketed drug might also have a company code or compound code.

Imgatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator.

Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis. It binds to IL17A and acts as an immunomodulator.

Emibetuzumab (INN) (LY2875358) is a humanized monoclonal antibody designed for the treatment of cancer. It is in phase II trials for patients with NSCLC

Lulizumab pegol is a monoclonal antibody designed for the treatment of autoimmune diseases.

Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritis.

Lifastuzumab vedotin is a monoclonal antibody designed for the treatment of cancer.

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran.

Seribantumab is a monoclonal antibody designed for the treatment of cancer.

Plozalizumab is a humanized monoclonal antibody designed for the treatment of diabetic nephropathy and arteriovenous graft patency.

Vobarilizumab is a humanized monoclonal antibody designed for the treatment of inflammatory autoimmune diseases.

Brazikumab is a human monoclonal antibody designed for the treatment of Crohn's disease.

Bleselumab is a human monoclonal antibody designed for the prevention of organ transplant rejection.

Carotuximab (INN) (TRC-105) is a chimeric monoclonal antibody designed for the treatment of cancer.

References

1 2 3 "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 29" (PDF). World Health Organization.
↑ Hudler, George (1998). Magical Mushrooms, Mischievous Molds . Princeton, New Jersey: Princeton University Press. pp. 112. ISBN 978-0-691-07016-2.

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[INN-1] 1 2 3 "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 29" (PDF). World Health Organization.

[2] Hudler, George (1998). Magical Mushrooms, Mischievous Molds . Princeton, New Jersey: Princeton University Press. pp. 112. ISBN 978-0-691-07016-2.

Names

IUPAC name N-[(11R,20R,21R,25S,26S)-6-[(1S,2S)-1,2-Dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis(1-hydroxyethyl)-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^9,13]heptacosan-18-yl]-4-(octyloxy)benzamide
Other names 1-[(4R,5R)-4,5-Dihydroxy-N²-[p-(octyloxy)benzoyl]-L-ornithine]echinocandin B^[1] (4R,5R)-4,5-Dihydroxy-N²-[p-(octyloxy)benzoyl]-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-L-threonyl-(3S,4S)-3-hydroxy-4-methyl-L-proline cyclic (6→1)-peptide^[1]
Identifiers
CAS Number	79404-91-4 ^Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL2103748 ^N
ChemSpider	5293334 ^N
MeSH	Cilofungin
PubChem CID	6918120
UNII	8ZJC54A39X ^Y
InChI InChI=1S/C49H71N7O17/c1-5-6-7-8-9-10-19-73-31-17-13-28(14-18-31)42(65)50-32-21-34(61)45(68)54-47(70)38-39(62)24(2)22-56(38)49(72)36(26(4)58)52-46(69)37(41(64)40(63)27-11-15-29(59)16-12-27)53-44(67)33-20-30(60)23-55(33)48(71)35(25(3)57)51-43(32)66/h11-18,24-26,30,32-41,45,57-64,68H,5-10,19-23H2,1-4H3,(H,50,65)(H,51,66)(H,52,69)(H,53,67)(H,54,70)/t24-,25+,26+,30+,32-,33-,34+,35-,36-,37-,38-,39-,40-,41-,45+/m0/s1^N Key: ZKZKCEAHVFVZDJ-MTUMARHDSA-N^N InChI=1/C49H71N7O17/c1-5-6-7-8-9-10-19-73-31-17-13-28(14-18-31)42(65)50-32-21-34(61)45(68)54-47(70)38-39(62)24(2)22-56(38)49(72)36(26(4)58)52-46(69)37(41(64)40(63)27-11-15-29(59)16-12-27)53-44(67)33-20-30(60)23-55(33)48(71)35(25(3)57)51-43(32)66/h11-18,24-26,30,32-41,45,57-64,68H,5-10,19-23H2,1-4H3,(H,50,65)(H,51,66)(H,52,69)(H,53,67)(H,54,70)/t24-,25+,26+,30+,32-,33-,34+,35-,36-,37-,38-,39-,40-,41-,45+/m0/s1 Key: ZKZKCEAHVFVZDJ-MTUMARHDBF
SMILES O=C2N5[C@H](C(=O)N[C@H](O)[C@H](O)C[C@H](NC(=O)c1ccc(OCCCCCCCC)cc1)C(=O)N[C@H](C(=O)N4[C@H](C(=O)N[C@H](C(=O)N[C@H]2[C@H](O)C)[C@H](O)[C@@H](O)c3ccc(O)cc3)C[C@@H](O)C4)[C@H](O)C)[C@@H](O)[C@@H](C)C5
Properties
Chemical formula	C₄₉H₇₁N₇O₁₇
Molar mass	1030.12474
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is ^YN ?)
Infobox references